LDX 3.33% 3.1¢ lumos diagnostics holdings limited

Ann: FY21 Annual Report, page-3

  1. 1,209 Posts.
    lightbulb Created with Sketch. 646
    Hiya, yes, I did attend. No, they didn't share any further verbal info about US FDA timeline (CEO just presented the Annual/Results Presentation material for most of the 30min).

    From my experience in other company applications, no ones knows the US FDA approval timeline for their application - this is naturally kept internal to the US gov body and companies know when things are approved when notified/pre-notified before info release.

    Only if the US FDA comes back for 'more info', 'clarifications', 'more testing data requested' etc one could surmise of some delays as public companies are obliged to then share the US FDA data request/delay..otherwise no FDA info request is generally taken as 'still in progress, gr8, no problems yet'. wink.png
 
watchlist Created with Sketch. Add LDX (ASX) to my watchlist
(20min delay)
Last
3.1¢
Change
0.001(3.33%)
Mkt cap ! $14.92M
Open High Low Value Volume
3.0¢ 3.2¢ 3.0¢ $59.53K 1.912M

Buyers (Bids)

No. Vol. Price($)
5 1117600 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 490000 4
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.